Devgen announces promising results of its nematicide field trials in banana plantations
Devgen NV provided a business update highlighting progress with its portfolio of programs and some key financials. In particular, Devgen announced the results of exploratory trials with its nematicide product under development in banana plantations. According to the company, the observed improvement in plant growth and "vigor", justifies a full fledged initiation of a development program on bananas, expanding the commercial opportunity for Devgen's nematicides. During the trials banana plants were treated with Devgen's product and another commercial available product as a standard.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Biograil secures seed funding for oral delivery device with potential to transform market for injectables
Ben-Gurion University of the Negev Alzheimer's Researcher demostrates specific immune response to vaccine

'Breathing' enzymes in fast motion - Researchers watch work of an enzyme in unprecedented detail
Diosynth Biotechnology enters long-term commercial supply agreement with Dendreon
